secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zomedica Corp. (ZOMDF)
CIK:        0001684144
Form:       8-K
Filed at:   2021-09-13T23:59:59+00:00
Accession:  0001171843-21-006450
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zomedica appoints Sean Whelan to Board; Wolfenberg resigns as director
----------------------------------------------------------------------

- Christopher Wolfenberg resigned from Zomedica Board effective Sept. 13, 2021, not due to any disagreement.
- Sean Whelan appointed to fill vacancy; will chair Audit Committee.
- Whelan is CEO of Encore Rehabilitation Services, former CFO of Diplomat and InfuSystem, and a CPA.
- Whelan received options for 800,000 common shares at $0.57/share, vesting over 4 years.
- The board change took effect immediately on September 13, 2021.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1684144/000117184321006450/0001171843-21-006450-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1684144/000117184321006450/f8k_091321.htm
  HTML page:      https://secwatch.observer/filing/0001171843-21-006450

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer